Browsing Tag
NASDAQ
807 posts
Lake Superior Acquisition Corp. closes $115m IPO as investors fully exercise overallotment option
Find out how Lake Superior Acquisition Corp. raised $115 million in its Nasdaq SPAC IPO and what investors expect from its next merger move.
Biotech meets blockchain: AlphaTON to tokenize cancer drug rights ahead of 2026 trial
Find out how AlphaTON and Cyncado plan to merge blockchain and biotech through tokenized cancer drug rights before their 2026 clinical trial begins.
How NANO Nuclear Energy’s $400m Nasdaq-priced offering could reshape the small reactor market
NANO Nuclear Energy raises $400M in oversubscribed Nasdaq-priced placement to scale its microreactor programs and lead next-gen nuclear commercialization.
AiRWA Inc. receives $30mn in Solana tokens as it tests blockchain-based U.S. equity settlements
Find out how AiRWA Inc.’s $30M Solana integration and blockchain-based equity settlement tests could reshape tokenized finance and hybrid trading.
Why Firefly Aerospace is betting $855m on SciTec — And what it means for investors watching the space-defense race.
Firefly Aerospace buys SciTec for $855M to fuse launch tech with defense AI analytics. Find out how this bold move could reshape space-security strategy.
Why Q/C Technologies’ 6.51m share registration could reshape its stock outlook in 2025
Discover why Q/C Technologies plans to register 6.51M shares for resale, what it signals to investors, and how it could impact QCLS stock.
Inside Algorhythm’s 10.1m share registration: could investor sentiment turn bearish after the filing?
Algorhythm Holdings (NASDAQ: RIME) registers 10.1 million shares for resale. Find out what this insider move means for investors and market sentiment.
Ovid Therapeutics (NASDAQ: OVID) surges 28% on $175m private placement: What does it mean for biotech investors?
Ovid Therapeutics (NASDAQ: OVID) jumped 28% after securing $175M via a PIPE deal. Explore its pipeline focus, stock sentiment, and investor outlook.
From IPO to $250M shelf: Can BioAge Labs keep investor faith in the race for anti-aging drugs?
BioAge Labs (NASDAQ: BIOA) files $250M mixed securities shelf to fuel its aging drug pipeline. See what it means for investors today.
Why Eos Energy’s 7.33m-share filing could reshape its stock outlook in 2025
Eos Energy Enterprises files to sell 7.33M shares. Learn how the equity raise impacts dilution, growth runway, and EOSE stock sentiment.